A decrease in BNIP3 levels in HepG2-SR cells has been reported [20], but researchers have not yet clearly determined how BNIP3L levels change; therefore, we measured the BNIP3 and BNIP3L protein levels in our HCC-SR cells using immunoblotting. Here, BNIP3L is linked to hepatocellular carcinoma.